|
Investigating the IL-1R Pathway in Anaplastic Large Cell Lymphoma for Targeted Therapy |
1 R01 CA259188-01 |
|
NCI |
2021 |
|
Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system |
1 R01 CA263806-01 |
BOTA, DANIELA ANNENELIE |
NCI |
2021 |
|
Therapeutic potential of targeting DNA repair deficiency in TSC |
1 R21 CA263133-01 |
|
NCI |
2021 |
|
Identifying the mechanisms of leukemia progression |
1 R35 CA253096-01A1 |
CRISPINO, JOHN D |
NCI |
2021 |
|
Elution of a Small Molecule from a Bio Ceramic Collagen Bone Graft Device Heals Bone while InhibitingBreast Cancer Bone Metastases |
2 R44 CA221553-02A1 |
|
NCI |
2021 |
|
Project 1: Developing Immune Checkpoint Controlled Release Biomaterials for Caner Immunotherapy |
2 U54 CA163066-11 |
|
NCI |
2021 |
|
The Role of CHAF1B in Maintaining Malignant Leukemia Stem Cells |
5 R00 CA230314-03 |
|
NCI |
2021 |
|
MR-Guided Precision Conformal Ablation Therapy for Brain Tumors |
5 R01 CA166379-09 |
|
NCI |
2021 |
|
Novel Path to Chronic Sensorimotor Dysfunction and Treatment for Chemotherapy |
5 R01 CA221363-04 |
COPE, TIMOTHY C |
NCI |
2021 |
|
Developmental regulation of apoptosis as a modifiable driver of radiotherapy-induced neurocognitive impairment in pediatric patients |
5 R37 CA248565-02 |
|
NCI |
2021 |